Calcium Antagonists During and After Myocardial Infarction

This publication has 37 references indexed in Scilit:

• Effects of metoprolol vs verapamil in patients with stable angina pectoris: The Angina Prognosis Study in Stockholm (APSIS)
  European Heart Journal, 1996
• The Risk of Myocardial Infarction Associated With Antihypertensive Drug Therapies
  JAMA, 1995
• Platelet aggregability in vivo is attenuated byverapamil but not bymetoprolol in patients with stable angina pectoris
  The American Journal of Cardiology, 1995
• Early administration of nifedipine in suspected acute myocardial infarction. The Secondary Prevention Reinfarction Israel Nifedipine Trial 2 Study.
  1993
• CALCIUM-CHANNEL BLOCKING AGENTS VERAPAMIL AND DILTIAZEM ARE INHIBITORS OF VASOPRESSIN-INDUCED HUMAN PLATELET ACTIVATION
  Clinical and Experimental Pharmacology and Physiology, 1991
• Calcium Antagonists in Secondary Prevention after Myocardial Infarction
  Drugs, 1991
• Effect of verapamil on mortality and major events after acute myocardial infarction (The Danish Verapamil Infarction Trial II — DAVIT II)
  The American Journal of Cardiology, 1990
• CONTROLLED TRIAL OF SOTALOL FOR ONE YEAR AFTER MYOCARDIAL INFARCTION
  The Lancet, 1982
• One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian multicentre trial.
  BMJ, 1982
• Verapamil in acute myocardial infarction.
  1980